http://rdf.ncbi.nlm.nih.gov/pubchem/reference/36161415

Outgoing Links

Predicate Object
contentType Journal Article
issn 0002-9270
1572-0241
publicationName The American journal of gastroenterology
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_1c0aa062611518a12552a116a65f748d
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_7fddba722953073048af62e8d6f67804
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_fa362d16a6cdd4f7ca31799639de0b36
bibliographicCitation Wang B, Zhou J, Wu X, Sun Y, Li L, Li P, Li M, Jiang W, Xu M, Feng B, Xu X, Cheng J, Xie W, Han T, Wang X, Li H, Piao H, Zhao X, Chen S, Meng T, Guan Q, Meng F, Kong Y, Ou X, Jia J, You H. Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial. Am J Gastroenterol. 2023 Dec 07;(). doi: 10.14309/ajg.0000000000002569. PMID: 37929952.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d38ec0c2178fc5ee9218f8d9114e8c33
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_741734cd7dc29bb1028a5f74caeee1c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ba8b35a688524e70d80d1d0d213cdd4d
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16ecb72cabfebc0d42ce248929e5d237
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_32d920684abe87867659bc734ab1bce3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ad1033273e4d0accc8fcecc64e4eed2
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c9efef776475415c79db799d9c6985db
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-5416-712X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_89ed3c9ac8daa6aa0446b47c6c21705c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_91a172cac6fbc01ce5e4a49c96bd8c8e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3cc9833a9d811969358a89796d9ac183
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_da03045bf7e17af2eb07d61a6aaba21f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-7314-8175
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5bfa6484ee2f8af0a3ca384a7627c578
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2873-575X
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5cce344a601ebc08f1b190c48389875
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a427691ce32a2d37578809548802eda7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-4673-8890
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4123-3030
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62db8d75a40c60f4e985d0af85789d40
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-4216-6968
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-2400-8413
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3233-5473
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-2586-1443
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ae0ff2ced00ff1a17ae648f10e2ccc86
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3fe519fd7b9e1e10809b94b75b33fd1e
date 2023-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.14309/ajg.0000000000002569
https://pubmed.ncbi.nlm.nih.gov/37929952
isPartOf https://portal.issn.org/resource/ISSN/1572-0241
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/426
https://portal.issn.org/resource/ISSN/0002-9270
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Carvedilol Plus NUC for Patients With HBV-Compensated Cirrhosis Under Virological Suppression: A Randomized Open-Label Trial

Total number of triples: 45.